StreetInsider.com News Articles

Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results

Thu, 09 Jul 2026 16:30:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- Darling Ingredients Inc. (NYSE: DAR) announced today that it will host a conference call on Thursday, July 30, 2026, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss second quarter 2026 financial results, which will be released earlier that day, and provide an update on company operations. A presentation with accompanying supplemental financial data will also be available at darlingii.com/investors.

To access the call as a listener, please register for the audio-only webcast.

To join the call as a participant to ask

Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results

Thu, 09 Jul 2026 16:30:00 -0400

To access the call as a listener, please register for the audio-only webcast.

To join the call as a participant to ask

Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results

Thu, 09 Jul 2026 16:30:00 -0400

To access the call as a listener, please register for the audio-only webcast.

To join the call as a participant to ask

Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results

Thu, 09 Jul 2026 16:30:00 -0400

To access the call as a listener, please register for the audio-only webcast.

To join the call as a participant to ask

Form 144 DARLING INGREDIENTS INC. Filed by: Mize Gary W.

Thu, 09 Jul 2026 15:22:00 -0400

si-local-file:///var/storage/secattach/20260709/26752940.html

Form 144 DARLING INGREDIENTS INC. Filed by: Mize Gary W.

Thu, 09 Jul 2026 15:22:00 -0400

si-local-file:///var/storage/secattach/20260709/26752940.html

Darling Ingredients (DAR) PT Raised to $62 at Barclays

Thu, 02 Jul 2026 04:11:48 -0400

Barclays analyst Theresa Chen raised the price target on Darling Ingredients (NYSE: DAR) to $62.00 (from $58.00) while maintaining a Equalweight rating.

Darling Ingredients (DAR) PT Lowered to $70 at TD Cowen

Tue, 23 Jun 2026 08:55:22 -0400

(Updated - June 23, 2026 8:55 AM EDT)

TD Cowen analyst Jason Gabelman lowered the price target on Darling Ingredients (NYSE: DAR) to $70.00 (from $76.00) while maintaining a Buy rating.

The analyst commented: "RINs Drive DAR Higher; DAR should be a primary beneficiary of a bullish RIN program set earlier this year that the US cannot meet with its own biofuel capacity. Recent RIN data and pricing supports this view, though it has not fully materialized in DAR equity. We see RIN prices and renewable diesel margins moving higher through the year, supporting high equity value and deleveraging. Summary Of Our

Darling Ingredients (DAR) PT Lowered to $70 at TD Cowen

Tue, 23 Jun 2026 08:55:22 -0400

(Updated - June 23, 2026 8:55 AM EDT)

TD Cowen analyst Jason Gabelman lowered the price target on Darling Ingredients (NYSE: DAR) to $70.00 (from $76.00) while maintaining a Buy rating.

Barclays Starts Darling Ingredients (DAR) at Equalweight

Mon, 22 Jun 2026 04:05:25 -0400

Barclays analyst Theresa Chen initiates coverage on Darling Ingredients (NYSE: DAR) with a Equalweight rating and a price target of $58.00.

The analyst comments: “DAR's investment case is supported by a favorable renewable fuels policy backdrop, with more stringent LCFS standards and record-high RVOs in 2026-2027 strengthening cash flows for Diamond Green Diesel (DGD), a 50/50 JV with VLO. However, we think a significant portion of this tailwind is likely already reflected in the current share price following DAR's impressive ~49% year-to-date rally (vs. SPX +9%). Despite recent market volatility, DAR's outperformance on a year-to-date basis raises the question of how

Barclays Starts Darling Ingredients (DAR) at Equalweight

Mon, 22 Jun 2026 04:05:25 -0400

Barclays analyst Theresa Chen initiates coverage on Darling Ingredients (NYSE: DAR) with a Equalweight rating and a price target of $58.00.

Darling Ingredients receives US patent for blood glucose collagen peptide

Wed, 03 Jun 2026 17:12:22 -0400

Darling Ingredients Inc. (NYSE: DAR) announced that the U.S. Patent and Trademark Office granted Patent No. US12636339 for Nextida GC, a collagen peptide ingredient designed to support blood glucose regulation after meals.

The patent covers both the production process and use of Nextida GC as a dietary supplement ingredient. The company describes the product as a non-pharmaceutical option for managing blood glucose through nutrition.

"This patent reinforces the scientific foundation behind Nextida GC and highlights Darling Ingredients' ability to translate its collagen expertise into targeted health solutions," said Randall C. Stuewe, Chairman and Chief Executive Officer.

Nextida GC is formulated for dietary supplement

Darling Ingredients’ Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation